Thomas Tørring
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Thomas Tørring has a total of 274 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Bjørnskov Poulsen
Department of Chemistry, Aarhus University, Aarhus, Denmark
18 shared publications - Kurt Vesterager Gothelf
Department of Chemistry and Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus Denmark
11 shared publications - Esben Bjerregaard Svenningsen
Department of Chemistry Aarhus University Langelandsgade 140, DK Aarhus C 8000 Denmark
7 shared publications - Jørgen Kjems
Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
6 shared publications Christian B. Rosen
Center for DNA Nanotechnology, Department of Chemistry and iNANO, Aarhus University, Gustav Wieds Vej14, 8000, Aarhus C, Denmark
5 shared publications- Søren Lau Borcher Møller
Department of Chemistry Aarhus University Langelandsgade 140, DK Aarhus C 8000 Denmark
5 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (11) , 3108-3116
Conjugation of a Cell-Penetrating Peptide to the Lasso Peptides Citrocin and Microcin J25 Enhances Antimicrobial Activity
A subset of lasso peptides function as antibiotics against Gram-negative bacteria by inhibition of the bacterial RNA polymerase (RNAP), including microcin J25 (MccJ25) and citrocin. These peptides interact with specific transporters in the inner and outer membranes of bacteria to gain access to the cytoplasm. The reliance on transporters limits the breadth of spectrum of these lasso peptide antibiotics and opens up paths to drug resistance. Here, we detail a strategy to overcome the transport limitations of lasso peptides: covalent conjugation of the lasso peptide to a cell penetrating peptide (CPP). Citrocin-CPP and MccJ25-CPP conjugates were synthesized by attaching the CPP to the loop of the lasso peptide and tested for antimicrobial activity against the ESKAPE pathogens. Citrocin-CPP and MccJ25-CPP have antimicrobial activity against all four Gram-negative ESKAPE pathogens, a broader spectrum of activity than the parent lasso peptides. Citrocin-CPP and MccJ25-CPP also exhibit more potent activity than the parent lasso peptides, with minimum inhibitory concentrations in the high nanomolar to single micromolar range. The uptake of citrocin-CPP and MccJ25-CPP was also studied in Escherichia coli revealing that the conjugates are internalized via both transporter-dependent and transporter-independent pathways.
- 26 October 2026
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (11) , 3108-3116
Open AccessConjugation of a Cell-Penetrating Peptide to the Lasso Peptides Citrocin and Microcin J25 Enhances Antimicrobial Activity
A subset of lasso peptides function as antibiotics against Gram-negative bacteria by inhibition of the bacterial RNA polymerase (RNAP), including microcin J25 (MccJ25) and citrocin. These peptides interact with specific transporters in the inner and outer membranes of bacteria to gain access to the cytoplasm. The reliance on transporters limits the breadth of spectrum of these lasso peptide antibiotics and opens up paths to drug resistance. Here, we detail a strategy to overcome the transport limitations of lasso peptides: covalent conjugation of the lasso peptide to a cell penetrating peptide (CPP). Citrocin-CPP and MccJ25-CPP conjugates were synthesized by attaching the CPP to the loop of the lasso peptide and tested for antimicrobial activity against the ESKAPE pathogens. Citrocin-CPP and MccJ25-CPP have antimicrobial activity against all four Gram-negative ESKAPE pathogens, a broader spectrum of activity than the parent lasso peptides. Citrocin-CPP and MccJ25-CPP also exhibit more potent activity than the parent lasso peptides, with minimum inhibitory concentrations in the high nanomolar to single micromolar range. The uptake of citrocin-CPP and MccJ25-CPP was also studied in Escherichia coli revealing that the conjugates are internalized via both transporter-dependent and transporter-independent pathways.
- 26 October 2026
- Published by Springer Nature in The Journal of Antibiotics
- p. 1-9
An unusual follower peptide is required for biosynthesis of the antibiotic lasso peptide triculamin
- 26 October 2026
- Published by Springer Nature in The Journal of Antibiotics
- p. 1-9
An unusual follower peptide is required for biosynthesis of the antibiotic lasso peptide triculamin
- Open Access
Heterologous Reconstitution of 4-Amidopentadienoate Biosynthesis Identifies the PKS Machinery Responsible for Warhead Formation
The 4-amidopentadienoate (APD) motif is a rare and bioactive pharmacophore found in the cyclic lipodepsipeptide natural products BE-43547, rakicidins, microtermolides, and related compounds. Although several biosynthetic gene clusters associated with this family have been identified, the enzymatic origin of the APD warhead has remained unknown. Here, we investigated APD formation using NRPS engineering to install the unusual APD-associated polyketide synthase (PKS) module from the BE-43547 biosynthetic pathway into heterologous nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) assembly lines expressed in Escherichia coli . The engineered hybrids produced the designed lipopeptide containing the APD moiety, demonstrating that the core biosynthetic machinery is sufficient for APD installation and that no trans-acting enzymes are required. Total synthesis of the target compound enabled structural validation by co-elution, MS/MS analysis, and NMR spectroscopy. Production titers of 59 ± 13 μg L −1 were achieved in the heterologous host. Systematic mutagenesis further revealed that the conserved dehydratase His-Asp catalytic dyad is essential for APD formation, whereas an additional highly conserved histidine is dispensable. These findings establish the biosynthetic origin of the APD warhead and provide a foundation for incorporating this privileged pharmacophore into engineered peptide scaffolds.
Open AccessHeterologous Reconstitution of 4-Amidopentadienoate Biosynthesis Identifies the PKS Machinery Responsible for Warhead Formation
The 4-amidopentadienoate (APD) motif is a rare and bioactive pharmacophore found in the cyclic lipodepsipeptide natural products BE-43547, rakicidins, microtermolides, and related compounds. Although several biosynthetic gene clusters associated with this family have been identified, the enzymatic origin of the APD warhead has remained unknown. Here, we investigated APD formation using NRPS engineering to install the unusual APD-associated polyketide synthase (PKS) module from the BE-43547 biosynthetic pathway into heterologous nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) assembly lines expressed in Escherichia coli . The engineered hybrids produced the designed lipopeptide containing the APD moiety, demonstrating that the core biosynthetic machinery is sufficient for APD installation and that no trans-acting enzymes are required. Total synthesis of the target compound enabled structural validation by co-elution, MS/MS analysis, and NMR spectroscopy. Production titers of 59 ± 13 μg L −1 were achieved in the heterologous host. Systematic mutagenesis further revealed that the conserved dehydratase His-Asp catalytic dyad is essential for APD formation, whereas an additional highly conserved histidine is dispensable. These findings establish the biosynthetic origin of the APD warhead and provide a foundation for incorporating this privileged pharmacophore into engineered peptide scaffolds.
- Open Access
- 26 August 2026
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (11) , 1863-1874
Topogenic sequence recognition at TIM complexes revealed by a stendomycin-bound structure
In the mitochondrial inner membrane (IM), topogenesis of imported proteins is mediated by TIM23 and TIM22 complexes. TIM23 translocates soluble polypeptides across the IM into the matrix, whereas TIM22 inserts polytopic membrane proteins into the IM. Although functionally distinct, both rely on homologous subunits, Tim17 in TIM23 and Tim22 in TIM22. The underlying mechanisms, however, remain elusive. Here we use structural and functional approaches with yeast Tim17, Tim22 and the TIM23 inhibitor stendomycin. Cryogenic-electron microscopy shows that stendomycin binds to the protein translocation cavity of Tim17, mimicking α-helical topogenic sequences. While Tim22 does not bind stendomycin, a single mutation in its equivalent cavity suffices to enable binding. The cavities of Tim17 and Tim22 are largely interchangeable without disrupting their functions. Lastly, stendomycin triggers a collapse of the membrane potential, likely via its Tim17- or Tim22-dependent translocation across the IM. These findings reveal a mechanistic overlap between protein translocases and insertases.
- 26 August 2026
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (11) , 1863-1874
Open AccessTopogenic sequence recognition at TIM complexes revealed by a stendomycin-bound structure
In the mitochondrial inner membrane (IM), topogenesis of imported proteins is mediated by TIM23 and TIM22 complexes. TIM23 translocates soluble polypeptides across the IM into the matrix, whereas TIM22 inserts polytopic membrane proteins into the IM. Although functionally distinct, both rely on homologous subunits, Tim17 in TIM23 and Tim22 in TIM22. The underlying mechanisms, however, remain elusive. Here we use structural and functional approaches with yeast Tim17, Tim22 and the TIM23 inhibitor stendomycin. Cryogenic-electron microscopy shows that stendomycin binds to the protein translocation cavity of Tim17, mimicking α-helical topogenic sequences. While Tim22 does not bind stendomycin, a single mutation in its equivalent cavity suffices to enable binding. The cavities of Tim17 and Tim22 are largely interchangeable without disrupting their functions. Lastly, stendomycin triggers a collapse of the membrane potential, likely via its Tim17- or Tim22-dependent translocation across the IM. These findings reveal a mechanistic overlap between protein translocases and insertases.
- Open Access
An Unusual Follower Peptide is Required for Biosynthesis of the Antibiotic Lasso Peptide Triculamin
Triculamin is a potent antibiotic lasso peptide first isolated in 1967. Previous studies have demonstrated that its biosynthesis follows a non-canonical logic unlike any other lasso peptide. In this study, we investigate the role of the unusual follower peptide and demonstrate that it is essential for efficient biosynthesis. Using structural prediction and targeted mutations of key conserved residues, we hypothesize that the interactions between the follower peptide and the macrocyclase create an enzyme-substrate complex that ensures delivery of the core peptide to the enzyme active site. Moreover, we demonstrate that analogs of the lasso peptide can be produced by modifying the core peptide, highlighting the substrate promiscuity of the lasso macrocyclase and identifying lysine-3 in the lasso peptide ring as the site of acetylation. Lastly, we achieve successful heterologous expression in Burkholderia sp . FERM 3421, which proves to be a superior heterologous host.
Open AccessAn Unusual Follower Peptide is Required for Biosynthesis of the Antibiotic Lasso Peptide Triculamin
Triculamin is a potent antibiotic lasso peptide first isolated in 1967. Previous studies have demonstrated that its biosynthesis follows a non-canonical logic unlike any other lasso peptide. In this study, we investigate the role of the unusual follower peptide and demonstrate that it is essential for efficient biosynthesis. Using structural prediction and targeted mutations of key conserved residues, we hypothesize that the interactions between the follower peptide and the macrocyclase create an enzyme-substrate complex that ensures delivery of the core peptide to the enzyme active site. Moreover, we demonstrate that analogs of the lasso peptide can be produced by modifying the core peptide, highlighting the substrate promiscuity of the lasso macrocyclase and identifying lysine-3 in the lasso peptide ring as the site of acetylation. Lastly, we achieve successful heterologous expression in Burkholderia sp . FERM 3421, which proves to be a superior heterologous host.
- Open Access
- 15 May 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (10) , e70378
Biosynthesis, Structure, and Antibiotic Properties of Gelatinamin A, a Triculamin‐Like Lasso Peptide
Lasso peptides are structurally unique natural products endowed with high thermal and proteolytic stability, making them attractive as scaffolds for drug discovery. Recently, a new class of lasso peptides containing a second macrocycle, formed between a lysine sidechain and the C‐terminus, was discovered, resulting in an even more compact architecture. Here, we report the first NMR structure of the class V lasso peptide, gelatinamin A. Using heterologous expression of the gelatinamin biosynthetic gene cluster (BGC) in Bacillus subtilis , we delineated the biosynthetic pathway through targeted gene deletions. We expressed and characterized the predicted transpeptidase, GelP, that catalyzes the formation of an isopeptide bond between Lys2 and the C‐terminus and mediates the reversible conversion of gelatinamin B to gelatinamin A. In addition, we characterize GelT, an N‐ acetyltransferase that inactivates lasso peptide antimicrobial activity by acetylating a key lysine residue. Furthermore, we demonstrate that gelatinamin is highly potent against several important pathogens and that the activity is strongly bicarbonate‐dependent. Finally, we propose a complete biosynthetic pathway for gelatinamin. The structural insight of gelatinamin A and the functional characterization of GelP provide the foundation for future discovery of class V lasso peptides and for engineering transpeptidases to modify other lasso peptide scaffolds.
- 15 May 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (10) , e70378
Open AccessBiosynthesis, Structure, and Antibiotic Properties of Gelatinamin A, a Triculamin‐Like Lasso Peptide
Lasso peptides are structurally unique natural products endowed with high thermal and proteolytic stability, making them attractive as scaffolds for drug discovery. Recently, a new class of lasso peptides containing a second macrocycle, formed between a lysine sidechain and the C‐terminus, was discovered, resulting in an even more compact architecture. Here, we report the first NMR structure of the class V lasso peptide, gelatinamin A. Using heterologous expression of the gelatinamin biosynthetic gene cluster (BGC) in Bacillus subtilis , we delineated the biosynthetic pathway through targeted gene deletions. We expressed and characterized the predicted transpeptidase, GelP, that catalyzes the formation of an isopeptide bond between Lys2 and the C‐terminus and mediates the reversible conversion of gelatinamin B to gelatinamin A. In addition, we characterize GelT, an N‐ acetyltransferase that inactivates lasso peptide antimicrobial activity by acetylating a key lysine residue. Furthermore, we demonstrate that gelatinamin is highly potent against several important pathogens and that the activity is strongly bicarbonate‐dependent. Finally, we propose a complete biosynthetic pathway for gelatinamin. The structural insight of gelatinamin A and the functional characterization of GelP provide the foundation for future discovery of class V lasso peptides and for engineering transpeptidases to modify other lasso peptide scaffolds.
- Open Access
- 20 February 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (2) , 001662
Hypoxia-induced production of the cyclolipodepsipeptide BE-43547 by Micromonospora sp. RV43
The urgent need for new antibiotics emphasizes the importance of investigating the many biosynthetic gene clusters that remain silent under standard culture conditions and of assigning functions to the many natural products already discovered. Conventional approaches, such as altering the screening medium composition or culture conditions to trigger production, are often labourious and disconnected from the function of the natural products. In this study, we combine antimicrobial assays and the controlled culture conditions available in benchtop bioreactors to demonstrate that BE-43547, a natural product that exists as a mixture of congeners, is selectively active against Gram-positive bacteria growing anaerobically. Furthermore, we show that the producing organism Micromonospora sp. RV43 activates the biosynthesis of BE-43547 when cultured under low-oxygen conditions. These findings illustrate that linking compound function and regulation cues can provide a powerful strategy for discovering antibiotics with a new mode of action.
- 20 February 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (2) , 001662
Open AccessHypoxia-induced production of the cyclolipodepsipeptide BE-43547 by Micromonospora sp. RV43
The urgent need for new antibiotics emphasizes the importance of investigating the many biosynthetic gene clusters that remain silent under standard culture conditions and of assigning functions to the many natural products already discovered. Conventional approaches, such as altering the screening medium composition or culture conditions to trigger production, are often labourious and disconnected from the function of the natural products. In this study, we combine antimicrobial assays and the controlled culture conditions available in benchtop bioreactors to demonstrate that BE-43547, a natural product that exists as a mixture of congeners, is selectively active against Gram-positive bacteria growing anaerobically. Furthermore, we show that the producing organism Micromonospora sp. RV43 activates the biosynthesis of BE-43547 when cultured under low-oxygen conditions. These findings illustrate that linking compound function and regulation cues can provide a powerful strategy for discovering antibiotics with a new mode of action.
- 23 December 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (1) , 249-257
Modular Total Synthesis of Lasalocid Acid A through Direct C(sp 3 )–C(sp 3 ) Attached Ring Construction
Lasalocid acid A is a natural product polyether antibiotic used in veterinary medicine to prevent parasitic infections which also displays potent inhibitory activity against drug-resistant Gram-positive bacteria and bacterial biofilms. The possibilities for improving the therapeutic potential of lasalocid acid A, through structural optimization, are restricted by the current, prohibitively lengthy syntheses required to construct the complex scaffold. Here, we report a highly concise and module-based synthesis of lasalocid acid A in 11 steps in the longest linear sequence, which is enabled by a new Tsuji-Trost C-glycosylation reaction to directly access the hindered, attached oxacyclic rings constituting the most challenging structural motif. This new reaction accomplishes the chemo-, regio-, and stereoselective C-C coupling of silyloxyfurans with acetoxy-dihydropyranones, affording a hindered C(sp3)-C(sp3) bond, including a quaternary stereocenter, and we demonstrate compatibility with multiple substrate variations. Overall, our results have afforded a new method allowing access to complex chiral scaffolds of relevance for medicinal chemistry and have unlocked the potential for conducting deep structural exploration of lasalocid acid A.
- 23 December 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (1) , 249-257
Modular Total Synthesis of Lasalocid Acid A through Direct C(sp 3 )–C(sp 3 ) Attached Ring Construction
Lasalocid acid A is a natural product polyether antibiotic used in veterinary medicine to prevent parasitic infections which also displays potent inhibitory activity against drug-resistant Gram-positive bacteria and bacterial biofilms. The possibilities for improving the therapeutic potential of lasalocid acid A, through structural optimization, are restricted by the current, prohibitively lengthy syntheses required to construct the complex scaffold. Here, we report a highly concise and module-based synthesis of lasalocid acid A in 11 steps in the longest linear sequence, which is enabled by a new Tsuji-Trost C-glycosylation reaction to directly access the hindered, attached oxacyclic rings constituting the most challenging structural motif. This new reaction accomplishes the chemo-, regio-, and stereoselective C-C coupling of silyloxyfurans with acetoxy-dihydropyranones, affording a hindered C(sp3)-C(sp3) bond, including a quaternary stereocenter, and we demonstrate compatibility with multiple substrate variations. Overall, our results have afforded a new method allowing access to complex chiral scaffolds of relevance for medicinal chemistry and have unlocked the potential for conducting deep structural exploration of lasalocid acid A.
- Open Access
Biosynthesis, Structure, and Antibiotic Properties of Gelatinamin A, a Triculamin-like Lasso Peptide
Lasso peptides are structurally unique natural products endowed with high thermal and proteolytic stability, making them attractive as scaffolds for drug discovery. Recently, a new class of lasso peptides containing a second macrocycle, formed between a lysine sidechain and the C-terminus, was discovered, resulting in an even more compact architecture. Here, we report the first NMR structure of the class V lasso peptide, gelatinamin A. Using heterologous expression of the gelatinamin biosynthetic gene cluster (BGC) in Bacillus subtilis , we delineated the biosynthetic pathway through targeted gene deletions. We expressed and characterized the predicted transpeptidase, GelP, that catalyzes the formation of an isopeptide bond between Lys2 and the C-terminus and mediates the reversible conversion of gelatinamin B to gelatinamin A. In addition, we characterize GelT, an N- acetyltransferase that inactivates lasso peptide antimicrobial activity by acetylating a key lysine residue. Furthermore, we demonstrate that gelatinamin is highly potent against several important pathogens and that the activity is strongly bicarbonate-dependent. Finally, we propose a complete biosynthetic pathway for gelatinamin. The structural insight of gelatinamin A and the functional characterization of GelP provide the foundation for future discovery of class V lasso peptides and for engineering transpeptidases to modify other lasso peptide scaffolds.
Open AccessBiosynthesis, Structure, and Antibiotic Properties of Gelatinamin A, a Triculamin-like Lasso Peptide
Lasso peptides are structurally unique natural products endowed with high thermal and proteolytic stability, making them attractive as scaffolds for drug discovery. Recently, a new class of lasso peptides containing a second macrocycle, formed between a lysine sidechain and the C-terminus, was discovered, resulting in an even more compact architecture. Here, we report the first NMR structure of the class V lasso peptide, gelatinamin A. Using heterologous expression of the gelatinamin biosynthetic gene cluster (BGC) in Bacillus subtilis , we delineated the biosynthetic pathway through targeted gene deletions. We expressed and characterized the predicted transpeptidase, GelP, that catalyzes the formation of an isopeptide bond between Lys2 and the C-terminus and mediates the reversible conversion of gelatinamin B to gelatinamin A. In addition, we characterize GelT, an N- acetyltransferase that inactivates lasso peptide antimicrobial activity by acetylating a key lysine residue. Furthermore, we demonstrate that gelatinamin is highly potent against several important pathogens and that the activity is strongly bicarbonate-dependent. Finally, we propose a complete biosynthetic pathway for gelatinamin. The structural insight of gelatinamin A and the functional characterization of GelP provide the foundation for future discovery of class V lasso peptides and for engineering transpeptidases to modify other lasso peptide scaffolds.
- Open Access
- 2 September 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (43)
P450 Enzyme LyoI Performs Hydro‐2,2′‐Bifuran Oxidation in the Polyether Ionophore Lysocellin
Polyether ionophores are potent antimicrobials, albeit also cytotoxic against mammalian cells. We have identified several polyether ionophores containing a common hydro‐2,2′‐bifuran‐2‐ol (hemiketal) moiety, which cannot be derived from the canonical biosynthetic steps observed for the compound class, suggesting an unusual oxidative transformation. To identify the responsible enzyme, we applied CRISPR–BEST to knock out genes in the lysocellin‐producing strain S. longwoodensis. This allowed us to propose the first annotation of the lysocellin biosynthetic gene cluster and identify the responsible P450 enzyme, LyoI, through reconstitution of the function in vivo. LyoI knockout provided access to the non‐oxidized precursor (pre‐lysocellin) which allowed both in vitro validation of the unusual direct hydro‐2,2′‐bifuran to hydro‐2,2′‐bifuran‐2‐ol oxidation and investigation of the impact on biological activity. Interestingly, absence of the LyoI‐mediated oxidation greatly reduced the biological potency of the compound. Closer investigation of the sequence revealed that LyoI lacks a key conserved acidic residue, which proved essential for the unusual oxidative function of the enzyme. Through a sequence similarity network of LyoI, we were able to identify a wide range of non‐canonical P450 enzymes, highlighting the possibilities of a biosynthesis‐focused approach to discovering novel enzymes.
- 2 September 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (43)
Open AccessP450 Enzyme LyoI Performs Hydro‐2,2′‐Bifuran Oxidation in the Polyether Ionophore Lysocellin
Polyether ionophores are potent antimicrobials, albeit also cytotoxic against mammalian cells. We have identified several polyether ionophores containing a common hydro‐2,2′‐bifuran‐2‐ol (hemiketal) moiety, which cannot be derived from the canonical biosynthetic steps observed for the compound class, suggesting an unusual oxidative transformation. To identify the responsible enzyme, we applied CRISPR–BEST to knock out genes in the lysocellin‐producing strain S. longwoodensis. This allowed us to propose the first annotation of the lysocellin biosynthetic gene cluster and identify the responsible P450 enzyme, LyoI, through reconstitution of the function in vivo. LyoI knockout provided access to the non‐oxidized precursor (pre‐lysocellin) which allowed both in vitro validation of the unusual direct hydro‐2,2′‐bifuran to hydro‐2,2′‐bifuran‐2‐ol oxidation and investigation of the impact on biological activity. Interestingly, absence of the LyoI‐mediated oxidation greatly reduced the biological potency of the compound. Closer investigation of the sequence revealed that LyoI lacks a key conserved acidic residue, which proved essential for the unusual oxidative function of the enzyme. Through a sequence similarity network of LyoI, we were able to identify a wide range of non‐canonical P450 enzymes, highlighting the possibilities of a biosynthesis‐focused approach to discovering novel enzymes.